Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

VetFamily Centrum Dyreklinik København ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   3.5% 3.4% 4.5% 6.8% 6.7% 3.2% 18.2% 18.2%   Credit score (0-100)   54 54 45 35 35 56 8 8   Credit rating   BBB BBB BBB BBB BBB BBB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,933 3,918 5,633 6,571 7,353 7,929 0.0 0.0   EBITDA   555 1,289 1,810 2,730 3,340 3,580 0.0 0.0   EBIT   470 1,201 1,721 2,637 3,250 3,538 0.0 0.0   Pre-tax profit (PTP)   452.0 1,232.6 1,751.4 2,618.2 3,245.2 3,625.2 0.0 0.0   Net earnings   351.9 961.4 1,373.6 2,009.7 2,530.9 2,827.6 0.0 0.0   Pre-tax profit without non-rec. items   452 1,233 1,751 2,618 3,245 3,625 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   354 267 200 149 133 146 0.0 0.0   Shareholders equity total   1,669 2,631 2,154 2,140 2,671 3,198 268 268   Interest-bearing liabilities   537 0.0 0.0 0.0 75.5 1,409 0.0 0.0   Balance sheet total (assets)   2,848 4,017 3,593 3,797 5,050 6,466 268 268   Net Debt   -984 -859 -517 -2,562 -1,776 -870 -268 -268     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,933 3,918 5,633 6,571 7,353 7,929 0.0 0.0   Gross profit growth   -13.3% 33.6% 43.8% 16.7% 11.9% 7.8% -100.0% 0.0%   Employees   0 8 8 9 9 10 0 0   Employee growth %   0.0% 0.0% 0.0% 12.5% 0.0% 11.1% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,848 4,017 3,593 3,797 5,050 6,466 268 268   Balance sheet change%   -3.4% 41.1% -10.6% 5.7% 33.0% 28.0% -95.9% 0.0%   Added value   554.7 1,288.8 1,809.7 2,729.5 3,342.2 3,580.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -206 -176 -155 -144 -107 -29 -146 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   16.0% 30.7% 30.6% 40.1% 44.2% 44.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   16.2% 36.1% 46.2% 71.4% 73.6% 63.0% 0.0% 0.0%   ROI %   21.9% 49.0% 70.9% 121.9% 132.8% 98.6% 0.0% 0.0%   ROE %   19.1% 44.7% 57.4% 93.6% 105.2% 96.4% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   58.6% 65.5% 60.0% 56.4% 52.9% 49.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -177.4% -66.7% -28.6% -93.9% -53.2% -24.3% 0.0% 0.0%   Gearing %   32.2% 0.0% 0.0% 0.0% 2.8% 44.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   6.7% 1.9% 0.0% 0.0% 31.7% 0.3% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   1.7 2.6 2.1 1.9 1.8 1.7 0.0 0.0   Current Ratio   2.0 2.8 2.3 2.1 1.9 1.8 0.0 0.0   Cash and cash equivalent   1,520.7 859.2 517.1 2,562.2 1,851.3 2,278.1 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,091.4 2,238.6 1,749.0 1,753.8 2,216.1 2,727.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 161 226 303 371 358 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 161 226 303 371 358 0 0   EBIT / employee   0 150 215 293 361 354 0 0   Net earnings / employee   0 120 172 223 281 283 0 0